Related Experiment Video
Updated: Jun 13, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Exposure to children as a risk factor for bacteremic pneumococcal disease: changes in the post-conjugate vaccine era
Joshua P Metlay1, Ebbing Lautenbach, Yimei Li
1Department of Medicine, University of Pennsylvania School of Medicine, 712 Blockley Hall, 423 Guardian Dr, Philadelphia, PA 19104, USA. jmetlay@mail.med.upenn.edu
Insights
Pneumococcal conjugate vaccine introduction shifted disease serotypes. Non-vaccine serotypes increased, while vaccine types declined, leading to an overall rise in adult bacteremic pneumococcal disease.
Area of Science:
- Epidemiology
- Infectious Diseases
- Vaccinology
Background:
- Pneumococcal conjugate vaccines (PCVs) have altered the landscape of bacteremic pneumococcal disease (BPD).
- Shifts in circulating serotypes causing BPD necessitate ongoing surveillance.
- Understanding evolving risk factors is crucial for public health strategies.
Purpose of the Study:
- To analyze recent trends in pneumococcal serotypes causing BPD in adults.
- To identify current risk factors associated with BPD in the post-PCV era.
Main Methods:
- Retrospective analysis of hospitalized adult patients with community-acquired BPD.
- Data collected from 48 acute care hospitals in the Philadelphia region (2002-2008).
- Serotyping of isolates and comparison of patient characteristics with regional population data.
Main Results:
- Annual BPD rates due to vaccine serotypes decreased by 29%, while non-vaccine serotypes increased by 13%.
- Overall adult BPD rates increased by 7% annually.
- Advanced age, African American ethnicity, smoking, and diabetes were significant risk factors.
- Increased number of children in the household was associated with decreased risk.
Conclusions:
- Emerging non-vaccine serotypes are replacing those targeted by current PCVs.
- Established risk factors like age and comorbidities persist.
- Household transmission dynamics may be shifting, potentially influenced by PCV introduction.
Background:
The introduction of a pneumococcal conjugate vaccine has been associated with a shift in the serotypes responsible for bacteremic pneumococcal disease. We examined recent trends in serotypes responsible for disease and current risk factors among adults.
Methods:
Data were obtained from 48 acute care hospitals in the 5-county region surrounding Philadelphia, Pennsylvania, from October 1, 2002, through September 30, 2008, on all hospitalized adult patients with community-acquired bacteremic pneumococcal disease. Isolates were serotyped and patient characteristics were compared with data from a household survey of the adult population in the region.
Results:
During the study period, the annual rate of disease due to vaccine serotypes declined by 29% per year, but the rate of disease due to nonvaccine serotypes increased 13% per year, yielding an overall 7% increase in the annual rate of disease among adults. Advanced age was a risk factor for infection with nonvaccine serotypes compared with vaccine serotypes. Comparing all patients with the source population, African Americans were at increased risk of infection, and the presence of additional children in the home was associated with decreased risk of disease. Smoking, advanced age, and diabetes mellitus remained important risk factors in adults.
Conclusions:
New serotypes are replacing the serotypes covered in the conjugate vaccine. While some risk factors for pneumococcal disease remain unchanged, the observation that exposure to children in the home is associated with lower risk of disease suggests that the changing epidemiology of pneumococcal disease may be altering the dominant modes of transmission in the community.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Vaccinations
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Development of Human Microbiota

